COLLABORATION AGREEMENTS - Neurodegenerative Diseases (Details) - Neurodegen Collaboration |
12 Months Ended | ||
|---|---|---|---|
|
Dec. 31, 2022
CAD ($)
|
Dec. 31, 2022
USD ($)
|
Dec. 31, 2021
USD ($)
|
|
| COLLABORATION AGREEMENTS | |||
| Maximum contribution amount per month | $ 12,500 | ||
| Amount contributed recorded in research and development expenses | $ 0 | $ 19,973 | |
| BCNI | |||
| COLLABORATION AGREEMENTS | |||
| Amount contributed | $ 0 | $ 19,973 | |
| X | ||||||||||
- Definition Represents the amount contributed. No definition available.
|
| X | ||||||||||
- Definition Represents the amount contributed recorded in research and development expenses. No definition available.
|
| X | ||||||||||
- Definition Represents the maximum contribution amount per month. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|